(Unregistered) (Unregistered)

トヨダテツヤ | (Unregistered) (Unregistered)

Affiliation and department：
Job title：副所長

Research field (1)： Virology

Research theme for competitive and other funds (14)：

2002 - 2003 Development of anti-virus agents on the basis of their ability to induce replicational errors
2002 - 2003 Identification of the etiological for Vibriovulnificus in patients with chronic liver diseasea.
1999 - 2000 Characterization of HCV replication and pathogenesis in animal model
1998 - 1999 RNAウイルスを用いた中枢神経向性ベクターの開発
1998 - 1999 フリーラジカルによるウイルス遺伝子変異メカニズムの解明

Show all

Papers (10)：

Shogo Nakajima, Koichi Watashi, Takanobu Kato, Masamichi Muramatsu, Takaji Wakita, Noriko Tamura, Shin-Ichiro Hattori, Kenji Maeda, Hiroaki Mitsuya, Yoshiaki Yasutake, et al. Correction for Nakajima et al., "Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations". Journal of virology. 2024. 98. 3. e0182323
中嶋章悟, 渡士幸一, 加藤孝宣, 村松正道, 脇田隆字, 安武義晃, 豊田哲也. エンテカビル耐性B型肝炎ウイルスポリメラーゼの生化学的および構造学的性質. 日本生化学会大会プログラム・講演要旨集. 2022. 95回. 2T08a-09
Shogo Nakajima, Koichi Watashi, Takanobu Kato, Masamichi Muramatsu, Takaji Wakita, Noriko Tamura, Shin-Ichiro Hattori, Kenji Maeda, Hiroaki Mitsuya, Yoshiaki Yasutake, et al. Biochemical and Structural Properties of Entecavir-Resistant Hepatitis B Virus Polymerase with L180M/M204V Mutations. Journal of virology. 2021. 95. 16. e0240120
Tetsuya Toyoda, Yongxiang Wang, Yumei Wen, Yasuhito Tanaka. Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity. Analytical biochemistry. 2020. 597. 113642-113642
Shogo Nakajima, Koichi Watashi, Kento Fukano, Senko Tsukuda, Kousho Wakae, Hideki Aizaki, Masamichi Muramatsu, Takaji Wakita, Tetsuya Toyoda. Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay. Journal of gastroenterology. 2020. 55. 4. 441-452

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page